Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Randomized, Double-Blind, Placebo-Controlled Study of Cinacalcet in Pediatric Chronic Kidney Disease
2010-023150-37Phase 3Terminated
- Sponsor
- Amgen
- Start
- Apr 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in chronic kidney disease (CKD) and secondary hyperparathyroidism (SHPT) comparing Cinacalcet with Placebo (2 arms). Primary endpoint: ≥30% reduction from baseline in mean plasma iPTH. Started Apr 2011; status: terminated.
02
Drugs
cinacalcet
03
Conditions
chronic kidney disease (CKD)secondary hyperparathyroidism (SHPT)
Beyond the preview
Go deeper on 2010-023150-37.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-023150-37.